Moderna Vaccine Is 96 Percent Effective in Teens, , Data Shows.
Moderna Vaccine Is 96 Percent Effective in Teens, , Data Shows.
The company released the data on May 6, along with its first quarter earnings.
The preliminary data showed a 96 percent efficacy rate for children between the ages of 12 and 17.
Moderna will submit full data to the Food and Drug Administration (FDA) later this month.
Moderna's COVID-19 vaccine was the second to receive a green light from the FDA after Pfizer's.
The success of the young company's vaccine also led to the first profit-making quarter in its history.
In the first quarter, the Moderna team delivered on its supply commitments to many governments and helped protect more than 100 million people, Stephane Bancel, Moderna CEO, via CNBC.
This accomplishment translated into our first profitable quarter in the company’s history, Stephane Bancel, Moderna CEO, via CNBC
